Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. The firm produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes. The firm operates globally though its subsidiaries: Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma Endocrinology, Inc. (Delaware, United States), Ascendis Pharma, Ophthalmology Division A/S (Denmark), Ascendis Pharma, Endocrinology Division A/S (Denmark), Ascendis Pharma Bone Diseases A/S (Denmark), Ascendis Pharma Growth Disorders A/S (Denmark) and Ascendis Pharma Oncology Division A/S (Denmark).
Mr. Jan Moller Mikkelsen is the President of Ascendis Pharma A/S, joining the firm since 2007.
What is the price performance of ASND stock?
The current price of ASND is $220.9, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Ascendis Pharma A/S?
Ascendis Pharma A/S belongs to Biotechnology industry and the sector is Health Care
What is Ascendis Pharma A/S market cap?
Ascendis Pharma A/S's current market cap is $13.3B
Is Ascendis Pharma A/S a buy, sell, or hold?
According to wall street analysts, 20 analysts have made analyst ratings for Ascendis Pharma A/S, including 11 strong buy, 11 buy, 1 hold, 0 sell, and 11 strong sell